WASHINGTON (Feb. 12, 2016) - The American College of Cardiology's National Cardiovascular Data Registry was the source of data for several research studies published in the final three months of 2015, including a study examining outcomes between certified and non-certified physicians, gender gaps in the use of oral anticoagulants, and appropriate use criteria.
Are There Differences in PCI Outcomes Between Certified and Non-Certified Physicians?
Physicians who received interventional cardiology certification through the American Board of Internal Medicine had similar outcomes following percutaneous coronary intervention as physicians without certification, according to a study published Sept. 18, 2015 in Circulation. The study was the first to evaluate the impact of interventional certification on patient outcomes in the 15 years since certification began. Using data from the ACC's CathPCI Registry, researchers assessed records from 510,708 patients who had undergone PCI performed by 5,175 physicians in 2010. Researchers looked at all-cause in-hospital mortality and bleeding complications as primary endpoints and emergency coronary artery bypass grafting and vascular complications requiring therapy as secondary endpoints. Read more: http://www.
Women With Non-Valvular AFib Less Likely to Receive Oral Anticoagulants Compared to Men
Significant gender gaps exist in use of oral anticoagulants to treat patients with non-valvular atrial fibrillation, accord to new research from the ACC's PINNACLE Registry presented as part of the American Heart Association meeting in Orlando. Specifically, women with an indication for anticoagulation are less likely than men to have oral anticoagulants prescribed across all strata of risk. The study looked at approximately 700,000 patients diagnosed with non-valvular AFib and indication for oral anticoagulants between May 2008 and December 2014. Patients were distributed across all high thromboembolic risk strata, with 47.8 percent of them identified as female. The primary outcome was prescription of an oral anticoagulant, including warfarin or a novel oral anticoagulant like dabigatran, rivaroxaban or apixaban. Overall, the data showed fewer than one in three patients with an indication for an oral anticoagulant received one, with women 9 to 30 percent less likely to have an oral anticoagulant prescribed compared to men of similar thromboembolic risk. The researchers did note a rapid increase in the use of novel anticoagulants in both men (53.5 percent each year) and women (57 percent each year) for non-valvular atrial fibrillation since U.S. Food and Drug Administration approval of dabigatran in 2010.
###Read more: http://www.
NCDR data was also used in studies previously highlighted during this time period:
Cardiac Patients Receive Comparable Care from Physicians, Advanced Practice Providers
Antiplatelet Therapy with Blood Thinners Reduces Mortality for Angioplasty Patients
Use of Rarely Appropriate Angioplasty Procedures Declined Sharply
First Outcomes Report from Novel Heart Surgery Registry Shows Excellent Results for Evolving TAVR Procedure
Chronic Kidney Disease Patients Benefit from Pacing Left and Right Ventricles
Treatment Time Lags for Heart Attack Patients with Prior Bypass Graft Surgery
The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit aac.org.